Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasia GI”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03035071
What this trial is testing

Morbidity in Open Versus Minimally Invasive Esophagectomy

Who this might be right for
Esophageal Cancer
Austrian Society Of Surgical Oncology 26
Post-approval studies (Phase 4)Study completedNCT00140036
What this trial is testing

Pharmacogenomics Blood Sampling Protocol For Irinotecan/Fluorouracil/Leucovorin(CPT-11/FU/LV).

Who this might be right for
Colorectal Neoplasms
Pfizer 137
Testing effectiveness (Phase 2)WithdrawnNCT00725400
What this trial is testing

Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
American Scitech International 450
Not applicableStudy completedNCT06244836
What this trial is testing

Comparison of Two Bundles of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat 2)

Who this might be right for
Colon CancerRectal CancerSurgical Site Infection
Hospital de Granollers 32,205
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Early research (Phase 1)Active Not RecruitingNCT04511871
What this trial is testing

A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Who this might be right for
Solid TumorGastric CancerBreast Cancer+2 more
Shanghai PerHum Therapeutics Co., Ltd. 12
Not applicableWithdrawnNCT00640692
What this trial is testing

Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial

Who this might be right for
Gastrointestinal Neoplasm
Oregon Health and Science University
Testing effectiveness (Phase 2)Study completedNCT00807911
What this trial is testing

Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

Who this might be right for
Rectal Cancer
Asan Medical Center 322
Testing effectiveness (Phase 2)WithdrawnNCT03879811
What this trial is testing

Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01111292
What this trial is testing

Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia

Who this might be right for
Colon CarcinomaDysplasia in Crohn DiseaseLow Grade Dysplasia in Ulcerative Colitis+1 more
National Cancer Institute (NCI) 5
Large-scale testing (Phase 3)Study completedNCT00000611
What this trial is testing

Women's Health Initiative (WHI)

Who this might be right for
Bone DiseasesBreast NeoplasmsCardiovascular Diseases+6 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)UnknownNCT01718626
What this trial is testing

Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hebei Tumor Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT00531115
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28
Not applicableUnknownNCT04917276
What this trial is testing

Treatment Response Prediction System of mCRC Patients Based on CTC

Who this might be right for
Colorectal Cancer Stage IVCirculating Tumor Cell
Fudan University 100
Not applicableUnknownNCT02552017
What this trial is testing

Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities

Who this might be right for
Colorectal NeoplasmsColonic PolypsAdenoma
South Tyneside and Sunderland NHS Foundation Trust 1,772
Not applicableStudy completedNCT05300789
What this trial is testing

Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer Patients

Who this might be right for
Peritoneal CarcinomatosisColon Cancer
Carlos Cerdán Santacruz 1,152
Not applicableStudy completedNCT04788368
What this trial is testing

TRECA - TREatment of Colorectal Adenomas and Early Colorectal CAncer in Region Västra Götaland

Who this might be right for
Rectal Neoplasms
Sahlgrenska University Hospital 300
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Not applicableLooking for participantsNCT07035691
What this trial is testing

New bioMarkers tO straTIfy cOlorectal caNcer Referrals

Who this might be right for
Colorectal CarcinomaPolypColorectal Adenoma
Queen Mary University of London 582
Not applicableStudy completedNCT05383976
What this trial is testing

Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 385
Next Page